From an HA1c control perspective, what is the advantage of using GLP-1 RAs in combination with long-acting insulin rather than as stand-alone therapy or as add-on to metformin?

From an HA1c control perspective, what is the advantage of using GLP-1 RAs in combination with long-acting insulin rather than as stand-alone therapy or as add-on to metformin?

From an HA1c control perspective, what is the advantage of using GLP-1 RAs in combination with long-acting insulin rather than as stand-alone therapy or as add-on to metformin?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

George Bakris, MD

George Bakris, MD

Professor of Preventive Medicine
Vice-Chairman, Department of Preventive Medicine
Rush Medical College
Chicago, Illinois